Copy to clipboard 
Smith+Nephew announces its efforts to develop technology in the field of Spatial Surgery for innovation in arthroscopic procedures. The company envisions Spatial Surgery as an opportunity to provide personalized planning, augmented reality and real-time data processing into platforms that interpret the surgical field intraoperatively.
Smith+Nephew has submitted to FDA a traditional 510(k) for a technology called the TESSA◊ Spatial Surgery System. If cleared by FDA, TESSA (Tracking Enabled Spatial Surgery Assistant) would combine a real-time, tracking-enabled device powered by a NVIDIA GPU. By using video processing and augmented reality guidance, TESSA would assist a surgeon in making anterior cruciate ligament reconstruction (ACLR) femoral tunnel decisions by navigating an operative plan.
TESSA is currently pending FDA clearance with proposed indications for use in anterior cruciate ligament surgical knee procedures in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony structures can be determined. Technical error is the second most common reason for ACLR failure, with femoral (29%) and tibial (11%) tunnel malposition being the most predominant for ACLR failure. If cleared by FDA, TESSA will aim to mitigate these technical failures through operative planning and intraoperative execution.
“We are excited to unveil our vision for Spatial Surgery – shaping the future of arthroscopic surgery by empowering healthcare professionals to utilize advanced technologies for patient personalization,” said Scott Schaffner, President of Global Sports Medicine at Smith+Nephew. “Challenging the status quo is what we do best, and we look forward to continuing the conversation and integrating Spatial Surgery as a core Sports Medicine discipline if cleared by FDA.”
Source: Smith+Nephew
Smith+Nephew announces its efforts to develop technology in the field of Spatial Surgery for innovation in arthroscopic procedures. The company envisions Spatial Surgery as an opportunity to provide personalized planning, augmented reality and real-time data processing into platforms that interpret the surgical field intraoperatively.
...
Smith+Nephew announces its efforts to develop technology in the field of Spatial Surgery for innovation in arthroscopic procedures. The company envisions Spatial Surgery as an opportunity to provide personalized planning, augmented reality and real-time data processing into platforms that interpret the surgical field intraoperatively.
Smith+Nephew has submitted to FDA a traditional 510(k) for a technology called the TESSA◊ Spatial Surgery System. If cleared by FDA, TESSA (Tracking Enabled Spatial Surgery Assistant) would combine a real-time, tracking-enabled device powered by a NVIDIA GPU. By using video processing and augmented reality guidance, TESSA would assist a surgeon in making anterior cruciate ligament reconstruction (ACLR) femoral tunnel decisions by navigating an operative plan.
TESSA is currently pending FDA clearance with proposed indications for use in anterior cruciate ligament surgical knee procedures in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony structures can be determined. Technical error is the second most common reason for ACLR failure, with femoral (29%) and tibial (11%) tunnel malposition being the most predominant for ACLR failure. If cleared by FDA, TESSA will aim to mitigate these technical failures through operative planning and intraoperative execution.
“We are excited to unveil our vision for Spatial Surgery – shaping the future of arthroscopic surgery by empowering healthcare professionals to utilize advanced technologies for patient personalization,” said Scott Schaffner, President of Global Sports Medicine at Smith+Nephew. “Challenging the status quo is what we do best, and we look forward to continuing the conversation and integrating Spatial Surgery as a core Sports Medicine discipline if cleared by FDA.”
Source: Smith+Nephew
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
